Salem Investment Counselors’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.32K | Hold |
651
| – | – | ﹤0.01% | 894 |
|
|
2025
Q1 | $3.71K | Sell |
651
-18,412
| -97% | -$105K | ﹤0.01% | 963 |
|
|
2024
Q4 | $187K | Sell |
19,063
-449
| -2% | -$4.41K | 0.01% | 373 |
|
|
2024
Q3 | $159K | Sell |
19,512
-50,995
| -72% | -$416K | ﹤0.01% | 396 |
|
|
2024
Q2 | $943K | Sell |
70,507
-48,458
| -41% | -$648K | 0.03% | 206 |
|
|
2024
Q1 | $5.52M | Buy |
118,965
+62,486
| +111% | +$2.9M | 0.18% | 82 |
|
|
2023
Q4 | $3.82M | Buy |
56,479
+6,770
| +14% | +$458K | 0.13% | 101 |
|
|
2023
Q3 | $3.6M | Buy |
49,709
+10,054
| +25% | +$728K | 0.14% | 99 |
|
|
2023
Q2 | $2.95M | Buy |
39,655
+4,232
| +12% | +$315K | 0.11% | 108 |
|
|
2023
Q1 | $1.88M | Buy |
35,423
+11,054
| +45% | +$588K | 0.08% | 131 |
|
|
2022
Q4 | $1.65M | Buy |
24,369
+408
| +2% | +$27.6K | 0.07% | 140 |
|
|
2022
Q3 | $2.99M | Buy |
23,961
+21,484
| +867% | +$2.68M | 0.14% | 101 |
|
|
2022
Q2 | $236K | Buy |
+2,477
| New | +$236K | 0.01% | 306 |
|